Squamous Cell Carcinoma of Unknown Primary Clinical Trials in Baltimore, Maryland

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment